The utility of medicare claims data for measuring cancer stage

Gregory S. Cooper, Zhong Yuan, Kurt C. Stange, Saeid B. Amini, Leslie K Dennis, Alfred A. Rimm

Research output: Contribution to journalArticle

76 Citations (Scopus)

Abstract

BACKGROUND. The validity of using claims data for measuring tumor stage, one of the most important determinants of choice of therapy and long-term survival, is unknown. OBJECTIVES. To determine the relative accuracy of both inpatient and hospital Outpatient Medicare claims for measuring the stage of disease of six commonly diagnosed cancers. RESEARCH DESIGN. Analysis of a database linking Surveillance, Epidemiology, and End Results (SEER) registry data and Medicare claims in patients aged 65 years with cancer. SUBJECTS. Three hundred twenty thousand, six hundred and thirty seven cases of invasive breast, colorectal, endometrial, lung, pancreatic, and prostate cancers diagnosed between 1984 and 1993. MEASURES. Using SEER files as the "gold standard," concordance with Medicare claims, as well as sensitivity and positive predictive value of coding for each stage was measured. RESULTS. Although Medicare data correctly categorized local, regional, and distant stage tumors in 97%, 33%, and 65%, respectively, the data substantially overestimated the proportion of localized tumors and underestimated the rate of regional stage disease. The highest concordance was observed for breast and colorectal cancer. However, the sensitivity and positive predictive values were never simultaneously 80% within one stage of a specific cancer. The accuracy of coding for stage in Outpatient files was inferior to inpatient data. CONCLUSIONS. With few exceptions, Medicare claims have limited utility as a measure of cancer stage. If tumor registry data are not available, investigators should consider the trade offs in sensitivity and predictive value when considering a study that will use claims data.

Original languageEnglish (US)
Pages (from-to)706-711
Number of pages6
JournalMedical Care
Volume37
Issue number7
DOIs
StatePublished - Jul 1999
Externally publishedYes

Fingerprint

Medicare
cancer
Neoplasms
epidemiology
surveillance
coding
Registries
Inpatients
Colorectal Neoplasms
Epidemiology
Outpatients
Disease
Breast Neoplasms
gold standard
Endometrial Neoplasms
Pancreatic Neoplasms
Lung Neoplasms
Prostatic Neoplasms
determinants
Research Personnel

Keywords

  • Breast neoplasms
  • Colorectal neoplasms
  • Endometrial neoplasms
  • Lung neoplasms
  • Pancreatic neoplasms
  • Prostatic neoplasms; medicare
  • Stage

ASJC Scopus subject areas

  • Nursing(all)
  • Public Health, Environmental and Occupational Health
  • Health(social science)
  • Health Professions(all)

Cite this

Cooper, G. S., Yuan, Z., Stange, K. C., Amini, S. B., Dennis, L. K., & Rimm, A. A. (1999). The utility of medicare claims data for measuring cancer stage. Medical Care, 37(7), 706-711. https://doi.org/10.1097/00005650-199907000-00010

The utility of medicare claims data for measuring cancer stage. / Cooper, Gregory S.; Yuan, Zhong; Stange, Kurt C.; Amini, Saeid B.; Dennis, Leslie K; Rimm, Alfred A.

In: Medical Care, Vol. 37, No. 7, 07.1999, p. 706-711.

Research output: Contribution to journalArticle

Cooper, GS, Yuan, Z, Stange, KC, Amini, SB, Dennis, LK & Rimm, AA 1999, 'The utility of medicare claims data for measuring cancer stage', Medical Care, vol. 37, no. 7, pp. 706-711. https://doi.org/10.1097/00005650-199907000-00010
Cooper, Gregory S. ; Yuan, Zhong ; Stange, Kurt C. ; Amini, Saeid B. ; Dennis, Leslie K ; Rimm, Alfred A. / The utility of medicare claims data for measuring cancer stage. In: Medical Care. 1999 ; Vol. 37, No. 7. pp. 706-711.
@article{ea712157a448468d9eae148c911f0653,
title = "The utility of medicare claims data for measuring cancer stage",
abstract = "BACKGROUND. The validity of using claims data for measuring tumor stage, one of the most important determinants of choice of therapy and long-term survival, is unknown. OBJECTIVES. To determine the relative accuracy of both inpatient and hospital Outpatient Medicare claims for measuring the stage of disease of six commonly diagnosed cancers. RESEARCH DESIGN. Analysis of a database linking Surveillance, Epidemiology, and End Results (SEER) registry data and Medicare claims in patients aged 65 years with cancer. SUBJECTS. Three hundred twenty thousand, six hundred and thirty seven cases of invasive breast, colorectal, endometrial, lung, pancreatic, and prostate cancers diagnosed between 1984 and 1993. MEASURES. Using SEER files as the {"}gold standard,{"} concordance with Medicare claims, as well as sensitivity and positive predictive value of coding for each stage was measured. RESULTS. Although Medicare data correctly categorized local, regional, and distant stage tumors in 97{\%}, 33{\%}, and 65{\%}, respectively, the data substantially overestimated the proportion of localized tumors and underestimated the rate of regional stage disease. The highest concordance was observed for breast and colorectal cancer. However, the sensitivity and positive predictive values were never simultaneously 80{\%} within one stage of a specific cancer. The accuracy of coding for stage in Outpatient files was inferior to inpatient data. CONCLUSIONS. With few exceptions, Medicare claims have limited utility as a measure of cancer stage. If tumor registry data are not available, investigators should consider the trade offs in sensitivity and predictive value when considering a study that will use claims data.",
keywords = "Breast neoplasms, Colorectal neoplasms, Endometrial neoplasms, Lung neoplasms, Pancreatic neoplasms, Prostatic neoplasms; medicare, Stage",
author = "Cooper, {Gregory S.} and Zhong Yuan and Stange, {Kurt C.} and Amini, {Saeid B.} and Dennis, {Leslie K} and Rimm, {Alfred A.}",
year = "1999",
month = "7",
doi = "10.1097/00005650-199907000-00010",
language = "English (US)",
volume = "37",
pages = "706--711",
journal = "Medical Care",
issn = "0025-7079",
publisher = "Lippincott Williams and Wilkins",
number = "7",

}

TY - JOUR

T1 - The utility of medicare claims data for measuring cancer stage

AU - Cooper, Gregory S.

AU - Yuan, Zhong

AU - Stange, Kurt C.

AU - Amini, Saeid B.

AU - Dennis, Leslie K

AU - Rimm, Alfred A.

PY - 1999/7

Y1 - 1999/7

N2 - BACKGROUND. The validity of using claims data for measuring tumor stage, one of the most important determinants of choice of therapy and long-term survival, is unknown. OBJECTIVES. To determine the relative accuracy of both inpatient and hospital Outpatient Medicare claims for measuring the stage of disease of six commonly diagnosed cancers. RESEARCH DESIGN. Analysis of a database linking Surveillance, Epidemiology, and End Results (SEER) registry data and Medicare claims in patients aged 65 years with cancer. SUBJECTS. Three hundred twenty thousand, six hundred and thirty seven cases of invasive breast, colorectal, endometrial, lung, pancreatic, and prostate cancers diagnosed between 1984 and 1993. MEASURES. Using SEER files as the "gold standard," concordance with Medicare claims, as well as sensitivity and positive predictive value of coding for each stage was measured. RESULTS. Although Medicare data correctly categorized local, regional, and distant stage tumors in 97%, 33%, and 65%, respectively, the data substantially overestimated the proportion of localized tumors and underestimated the rate of regional stage disease. The highest concordance was observed for breast and colorectal cancer. However, the sensitivity and positive predictive values were never simultaneously 80% within one stage of a specific cancer. The accuracy of coding for stage in Outpatient files was inferior to inpatient data. CONCLUSIONS. With few exceptions, Medicare claims have limited utility as a measure of cancer stage. If tumor registry data are not available, investigators should consider the trade offs in sensitivity and predictive value when considering a study that will use claims data.

AB - BACKGROUND. The validity of using claims data for measuring tumor stage, one of the most important determinants of choice of therapy and long-term survival, is unknown. OBJECTIVES. To determine the relative accuracy of both inpatient and hospital Outpatient Medicare claims for measuring the stage of disease of six commonly diagnosed cancers. RESEARCH DESIGN. Analysis of a database linking Surveillance, Epidemiology, and End Results (SEER) registry data and Medicare claims in patients aged 65 years with cancer. SUBJECTS. Three hundred twenty thousand, six hundred and thirty seven cases of invasive breast, colorectal, endometrial, lung, pancreatic, and prostate cancers diagnosed between 1984 and 1993. MEASURES. Using SEER files as the "gold standard," concordance with Medicare claims, as well as sensitivity and positive predictive value of coding for each stage was measured. RESULTS. Although Medicare data correctly categorized local, regional, and distant stage tumors in 97%, 33%, and 65%, respectively, the data substantially overestimated the proportion of localized tumors and underestimated the rate of regional stage disease. The highest concordance was observed for breast and colorectal cancer. However, the sensitivity and positive predictive values were never simultaneously 80% within one stage of a specific cancer. The accuracy of coding for stage in Outpatient files was inferior to inpatient data. CONCLUSIONS. With few exceptions, Medicare claims have limited utility as a measure of cancer stage. If tumor registry data are not available, investigators should consider the trade offs in sensitivity and predictive value when considering a study that will use claims data.

KW - Breast neoplasms

KW - Colorectal neoplasms

KW - Endometrial neoplasms

KW - Lung neoplasms

KW - Pancreatic neoplasms

KW - Prostatic neoplasms; medicare

KW - Stage

UR - http://www.scopus.com/inward/record.url?scp=0033159326&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0033159326&partnerID=8YFLogxK

U2 - 10.1097/00005650-199907000-00010

DO - 10.1097/00005650-199907000-00010

M3 - Article

C2 - 10424641

AN - SCOPUS:0033159326

VL - 37

SP - 706

EP - 711

JO - Medical Care

JF - Medical Care

SN - 0025-7079

IS - 7

ER -